Trademark: 97882678
Status Date
Tuesday, May 28, 2024
Filing Date
Tuesday, April 11, 2023
Published for Opposition
Tuesday, May 28, 2024
5 Medicated liquid formulation for the prevention and management of the signs and symptoms of oral mucositis caused by radiation or chemotherapy for therapeutic purposes; Medicated liquid formulation for the prevention and management of mucositis, stomatitis, aphthous ulcers, traumatic ulcers and other oral wounds for pharmaceutical purposes
The mark consists of a droplet in the colors gray, dark purple and light purple with a blank space in the middle. The color white is not claimed as a feature of the mark.
The color(s) gray, dark purple, and light purple is/are claimed as a feature of the mark.
Apr 14, 2023
New Application Entered
May 5, 2023
New Application Office Supplied Data Entered
May 6, 2023
Notice Of Design Search Code E-Mailed
Jan 8, 2024
Assigned To Examiner
Jan 10, 2024
Priority Action Written
Jan 10, 2024
Priority Action E-Mailed
Jan 10, 2024
Notification Of Priority Action E-Mailed
Apr 10, 2024
Teas/Email Correspondence Entered
Apr 10, 2024
Correspondence Received In Law Office
May 8, 2024
Notification Of Notice Of Publication E-Mailed
May 28, 2024
Published For Opposition
May 28, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 25, 2024
Approved For Pub - Principal Register
Apr 10, 2024
Teas Response To Office Action Received
Trademark Alertz updated from USPTO on 2030-01-24
